UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 370, Issue 9582, pp. 153 - 160
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Carotid Arteries - drug effects | Dyslipidemias - drug therapy | Double-Blind Method | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Heptanoic Acids - adverse effects | Anticholesteremic Agents - adverse effects | Tunica Intima - drug effects | Atorvastatin Calcium | Dyslipidemias - blood | Anticholesteremic Agents - therapeutic use | Tunica Intima - pathology | Pyrroles - adverse effects | Female | Blood Pressure - drug effects | Quinolines - therapeutic use | Pyrroles - therapeutic use | Quinolines - adverse effects | Studies | Medical research | Digital imaging | Diet | Mortality | Cardiovascular disease | Metabolic syndrome | Protocol | Low density lipoprotein | Patients | Cholesterol | Veins & arteries | Lipoproteins (low density) | Laboratories | Clinical trials | Segments | Density | Evidence-based medicine | Carotid arteries | Blood | Proteins | Randomization | Ultrasonic imaging | Radiance | Atherosclerosis | Blood pressure | Lipoproteins (high density) | Ultrasound | Media | Triglycerides | Cholesteryl ester transfer protein | Arteriosclerosis | Atorvastatin | Titration | Diabetes | Health risk assessment | Mercury | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2009, Volume 301, Issue 3, pp. 295 - 303
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Anxiety disorders. Neuroses | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Psychiatric Status Rating Scales | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Aged, 80 and over | Citalopram - therapeutic use | Female | Male | Aged | Anxiety Disorders - drug therapy | Psychological aspects | Usage | Care and treatment | Generalized anxiety disorder | Memory in old age | Placebos | Serotonin uptake inhibitors | Comparative analysis | Inhibitor drugs | Product safety | Anxieties | Older people | Medical treatment | Placebo effect | Index Medicus | Abridged Index Medicus | Preliminary Communication
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2005, Volume 352, Issue 14, pp. 1425 - 1435
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Prospective Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Risk | Alanine Transaminase - blood | Heptanoic Acids - adverse effects | Incidence | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Adult | Cholesterol, LDL - blood | Female | Pyrroles - therapeutic use | Coronary Disease - blood | Anticholesteremic Agents - adverse effects | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Anticholesteremic Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Coronary Disease - drug therapy | Aged | Measurement | Cholesterol, LDL | Care and treatment | Lipids | Cardiovascular disease | Drug therapy | Patients | Low density lipoprotein | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1517 - 1526
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypercholesterolemia - immunology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Injections, Subcutaneous - adverse effects | Proprotein Convertase 9 - immunology | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Anticholesteremic Agents - immunology | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Lipids - blood | Proprotein Convertase 9 - blood | Antibodies - blood | Cholesterol, LDL - blood | Female | Antibodies, Monoclonal, Humanized - immunology | Complications and side effects | Treatment outcome | Immune response | Patient outcomes | Analysis | Dosage and administration | Antilipemic agents | Lipoproteins (low density) | Hyperlipidemia | Clinical trials | Lipids | Subtilisin | Patients | Low density lipoprotein | Cholesterol | Studies | Apolipoprotein B | Kexin | Monoclonal antibodies | Statins | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
JAMA psychiatry (Chicago, Ill.), ISSN 2168-622X, 07/2016, Volume 73, Issue 7, pp. 685 - 694
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Grief | Double-Blind Method | Comorbidity | Humans | Middle Aged | Depressive Disorder - diagnosis | Psychotherapy | Depressive Disorder - drug therapy | Male | Treatment Outcome | Combined Modality Therapy | Adjustment Disorders - diagnosis | Adjustment Disorders - drug therapy | Adjustment Disorders - psychology | Adult | Citalopram - therapeutic use | Female | Aged | Depressive Disorder - psychology | Usage | Care and treatment | Antidepressants | Health aspects | Citalopram | Index Medicus | Abridged Index Medicus | Depressive Disorders | Bereavement | SSRIs | Americans | Survivors | Traumatic Grief | Treatment Compliance | Randomized Clinical Trial | Treatment Effectiveness | Suicidality | Quality of Life | Adults | Psychotherapeutic Processes | Manual-Based Treatments | Avoidance
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2007, Volume 356, Issue 13, pp. 1304 - 1316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | General aspects | Medical sciences | Atherosclerosis (general aspects, experimental research) | Blood and lymphatic vessels | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Prospective Studies | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Ultrasonography, Interventional | Male | Cholesterol Ester Transfer Proteins - adverse effects | Coronary Artery Disease - pathology | Adult | Cholesterol, LDL - blood | Female | Blood Pressure - drug effects | Drug Therapy, Combination | Pyrroles - therapeutic use | Double-Blind Method | Cholesterol, HDL - metabolism | Coronary Artery Disease - drug therapy | Anticholesteremic Agents - adverse effects | Disease Progression | Atorvastatin Calcium | Coronary Artery Disease - diagnostic imaging | Anticholesteremic Agents - therapeutic use | Cholesterol, HDL - blood | Aged | Cardiovascular Diseases - chemically induced | Quinolines - therapeutic use | Quinolines - adverse effects | Prevention | Causes of | Risk factors | Atherosclerosis | Lipoproteins | Ultrasonic imaging | Medical imaging | Clinical trials | Cardiovascular disease | Blood pressure | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 21, pp. 2109 - 2122
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Coronary heart disease | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Cardiovascular Diseases - drug therapy | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Heptanoic Acids - adverse effects | Coronary Disease - mortality | Cardiovascular Diseases - mortality | Pyrroles - adverse effects | Cholesterol, LDL - blood | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Double-Blind Method | Mortality | Anticholesteremic Agents - adverse effects | Atorvastatin Calcium | Coronary Disease - prevention & control | Anticholesteremic Agents - therapeutic use | Cholesterol, HDL - blood | Aged | Cardiovascular Diseases - chemically induced | Quinolines - therapeutic use | Quinolines - adverse effects | Clinical trials | Cardiovascular disease | Side effects | Pharmacology | Inhibitor drugs | Cholesterol | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2007, Volume 356, Issue 16, pp. 1620 - 1630
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | General aspects | Medical sciences | Atherosclerosis (general aspects, experimental research) | Blood and lymphatic vessels | Carotid Arteries - drug effects | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Prospective Studies | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Quinolines - pharmacology | Atherosclerosis - etiology | Carotid Artery Diseases - pathology | Adult | Cholesterol, LDL - blood | Female | Hyperlipoproteinemia Type II - drug therapy | Drug Therapy, Combination | Pyrroles - therapeutic use | Carotid Artery Diseases - drug therapy | Hyperlipoproteinemia Type II - complications | Atherosclerosis - pathology | Atherosclerosis - drug therapy | Carotid Artery Diseases - etiology | Double-Blind Method | Hyperlipoproteinemia Type II - blood | Disease Progression | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Cholesterol, HDL - blood | Heterozygote | Carotid Arteries - pathology | Quinolines - therapeutic use | Anticholesteremic Agents - pharmacology | Hypercholesterolemia | High density lipoproteins | Atherosclerosis | Anticholesteremic agents | Dosage and administration | Research | Drug therapy | Cardiovascular disease | Diet | Apolipoproteins | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
General hospital psychiatry, ISSN 0163-8343, 2006, Volume 28, Issue 4, pp. 306 - 312
Depression | Hemodialysis | Mortality | Symptoms | Quality of life | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Emergency and intensive care: renal failure. Dialysis management | Psychology. Psychoanalysis. Psychiatry | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Intensive care medicine | Medical sciences | Depressive Disorder, Major - etiology | Demography | Renal Dialysis - psychology | Risk Assessment | Humans | Middle Aged | Male | Depressive Disorder, Major - psychology | Renal Dialysis - mortality | Adolescent | Kidney Failure, Chronic - rehabilitation | Aged, 80 and over | Female | Surveys and Questionnaires | Aged | Quality of Life - psychology | Depressive Disorder, Major - diagnosis | Medical colleges | Kidney diseases | Patient outcomes | Depression, Mental | Index Medicus
Journal Article